Recombinant Human IL-7R alpha/CD127 Protein,hFc Tag

Scan for product

HEK293表达系统抗体药物靶点研究重组蛋白研究

Product no.93741ES Sizes4 options SourceYeasen · Official

Cat. No. 93741ES60

现货 ¥3,265.00

Qty 1

Enquire now

Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status

93741ES60 100 μg ¥3,265.00 现货 Enquire

93741ES76 500 μg ¥11,215.00 现货 Enquire

93741ES25 25 μg ¥895.00 现货 Enquire

93741ES25-EN 25 μg-EN ¥895.00 现货 Enquire

Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen

Cat.No93741ES

Specification高纯度、高活性、低内毒素、高批间一致性

Origin翌圣生物科技(上海)股份有限公司

技术平台 HEK293表达系统

应用方法 抗体药物靶点研究作为靶点蛋白用于抗体药物筛选和开发 重组蛋白研究作为工具蛋白用于体外实验

适用物种种属人

检测方法 SDS-PAGE HPLC LAL法 ELISA Tris-Bis PAGE

生物特性参数 蛋白类型重组蛋白 种属来源人 生物活性描述Immobilized Human IL-7 at 0.5μg/ml (100μl/Well) on the plate. Dose response curve for Human IL-7R alpha hFc Tag with the EC50 of 55.1ng/ml determined by ELISA 应用抗体药物靶点蛋白研究 蛋白登记号P16871-1 产品别称IL-7R alpha IL7Ra CD127 CDW127 ILRA

样本类型 重组蛋白

技术参数纯度> 95% as determined by SDS-PAGE and HPLC. 内毒素水平< 1.0 EU per μg by the LAL method. 分子量Predicted MW 51.6 kDa; migrates to 65-75 kDa by Tris-Bis PAGE due to glycosylation. 制剂形式Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization. 表达序列Glu21-Gly236 表达系统HEK293 标签C-hFc 活性EC50 of 55.1 ng/ml determined by ELISA 复溶方法开盖之前，先离心。使用蒸馏水复溶冻干的蛋白质，复溶浓度超过100 μg/mL。建议首次使用时将蛋白分装为每次实验用量，避免反复冻融。 储存条件-25 ~ -15℃保存，收到货之后有效期1年。复溶后，无菌条件下，-85 ~ -65℃保存，3个月有效期。 外观Lyophilized Powder